findmyKOL

Jesse Krakauer, MD

Basic profile

Beaumont Hospital

ORCIDNPI
RegionBerkley, MI · MidwestSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Active KOLEmergingfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Jesse Krakauer is an Endocrinology/Metabolic physician affiliated with Beaumont Hospital. OpenAlex indexes 50 publications with 2,914 citations (h-index 19).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
50publications

Distinct works indexed by OpenAlex, matched via ORCID.

2,914citations

Total citations across indexed works.

19h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
5companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

2905 12 Mile Rd
Berkley, MI 480721413

Telephone

248-541-0770

Provider last certified this registry record 24 Jan 2025.

View the NPPES registry record

Industry payments

5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    65.9%
    GLP-1 receptor agonist27.4%
    Mounjaro50%Ozempic39%Trulicity11%
    Part D41 patients
    Insulin Analog12.7%
    Lantus Solostar26%Novolog Flexpen18%Tresiba Flextouch U-20018%Novolog11%Humalog Kwikpen U-1007%Basaglar Kwikpen U-1006%Tresiba Flextouch U-1005%Admelog Solostar4%Insulin Lispro Kwikpen U-1004%
    Part D<11 patients

    + 6 more classes in this area

  • Cardiovascular

    18.1%
    Statin6.5%
    Rosuvastatin Calcium54%Atorvastatin Calcium35%Simvastatin12%
    Part D<11 patients
    Angiotensin receptor blocker (ARB)3.9%
    Losartan Potassium100%
    Part D20 patients

    + 6 more classes in this area

  • Hormonal (systemic)

    9.5%
    l-Thyroxine8.3%
    Levothyroxine Sodium100%
    Part D40 patients
    l-Triiodothyronine0.7%
    Liothyronine Sodium100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”